Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Protein A Resin Market: By Matrix Type, By Application By End User and Geography
Protein A Resin Market: By Matrix Type, By Application By End User and Geography
Protein A Resin Market size was valued at US$ 1.32 billion in 2022. It is expected to reach a value of US$ 2.05 billion by 2029, growing at a CAGR of 6.5% from 2023-29. Protein A is a surface protein that originally found in cell wall of bacteria staphylococcus aureus. It has many applications in biopharmaceutical and biochemical industry especially in monoclonal antibodies purification. Protein A Resin Market is a chromatographic medium that is used to analyse and separate the antibodies. Because of its ability to bind immunoglobulins protein A resin is also used in immunological research.
Nowadays protein A resins produced mostly using recombinant DNA technology in Escherichia coli. Companies in Protein A Resin market are investing in research and development to gain the competitive advantage. Additionally, the global industry is developing as a result of a biotechnology and biopharmaceutical industry expansion in the drug development process, growing research into monoclonal antibodies, and rising spending on synthetic biology. In addition, the demand for protein-engineered products utilised in the development of vaccines and medicines by the biopharmaceutical sectors is rising, which is one of the key reasons driving the business globally.
Study Period
2024-2030Base Year
2023CAGR
6.5%Largest Market
North AmericaFastest Growing Market
Asia Pacific
A wide range of applications in biopharmaceutical industry, increasing biological products pipeline, increasing use and development of newer technologies for drug purification are expected to drive the growth of protein A resins market over forecast period. Furthermore, advantages over conventional chromatographic separation of antibodies such as high selectivity, improved antibody yield along with ease in large and small scale antibody purification may further drive protein a resins market. However, high-cost of Protein A resin purification method in comparison with conventional chromatographic separation techniques hindering the protein A resin market growth. In addition, development of alternatives for protein A resins such as aqueous two phase separation, mixed mode chromatography and cation exchange may hamper the protein A resins market during forecast period.
Geographically protein a resin market segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the market revenue share among the all regions due to technological advancements, well-established healthcare industry and favourable government policies. In addition, growth of monoclonal antibodies market in U.S. directly contributing to growth of effective antibody purifying techniques and related products & services. Protein A resin market is expected to grow at significant rate in Asia Pacific region due to shifting the global interest for manufacturing in biopharmaceutical manufacturing capacities in emerging economies of the region like India and China. Europe growth in monoclonal antibodies sales may drive the revenue growth of protein A resin market in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2022 |
US$ 1.32 billion |
|
Market Size in 2029 |
US$ 2.05 billion |
|
Market CAGR |
6.5% |
|
By Matrix Type |
|
|
By Application |
|
|
By End-User |
|
|
By Region |
|
Download Free Sample Report
The protein a resin market size was valued at US$ 1.32 billion in 2022
The key segments covered in the protein a resin market are: by matrix type, application and end user
The protein a resin market key players are: Novasep, GE Healthcare, Thermo Fisher Scientific, Merck, Tosoh Corporation, Repligen Corporation
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.